I would just say, you know, looking ahead to 2026, we're focused on improving the core business. You know, years ago, when we ...
Dr Karsten Eastman, CEO, Sethera Therapeutics, highlights the challenges around ‘true’ diversification in DNA libraries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback